Tentarix Biotherapeutics Announces the Appointment of Andrew D. Kidd, MD, CFA, as CEO

Download

• Small JPEG, 200x120, 20.5 KB
• Preview JPEG, 144x86, 12.8 KB
• Thumbnail JPEG, 117x70, 10.0 KB